UPDATE: SunTrust Robinson Humphrey Reiterates on Hologic as Deterioration Story Gains Momentum
November 12, 2013 at 09:41 AM EST
In a report published Tuesday, SunTrust Robinson Humphrey analyst Amit Hazan reiterated a Reduce rating on Hologic (NASDAQ: HOLX ), but lowered the price target from $17.00 to $15.00. In the report, SunTrust Robinson Humphrey noted, “New guidance for FY14 reflects the reality of deteriorating end markets and only the
